Friday 6 November 2026 Export KNSA’s income statement to Excel — free account

Kiniksa Pharmaceuticals International, plc

KNSA Healthcare Drug Manufacturers Specialty & Generic

Kiniksa Pharmaceuticals International, plc’s revenue for fiscal 2025 (year ended December 2025) was $677.6 million, up 60.1% from fiscal 2024.

Revenue: +58.1%
EPS: +142.2%
Free cash flow: +43.5%

Quarter to September 2026, against a year earlier

94.14 5.80 +6.57%

Follow KNSA

Alert me

Market cap: $6.9B
P/E: 62.1×
Fwd P/E: 67.8×
Dividend yield: —
F-score: 8/9
Altman Z: 10.35
Beneish M: −3.16
Dividend safety: n/a

Overview Business Profile Earnings & Analysis Segments Valuation Filings

	Older periods	Dec '25	Mar '26	Jun '26	Sep '26
P/E ratio Full definition →	+8 more quarters Free account	51.56	49.13	59.77	52.34
P/S ratio Full definition →		4.52	4.89	5.90	6.17
P/FCF ratio Full definition →		22.42	22.42	27.12	29.57
P/Operating CF Full definition →		56.79	73.39	105.12	122.70
P/B ratio Full definition →		5.39	6.08	7.58	8.21
Price to Tangible BV Full definition →		5.54	6.24	7.76	8.39
EV/Sales Full definition →		3.91	4.27	5.27	5.57
EV/EBITDA Full definition →		33.60	33.89	43.46	39.78
EV/Operating CF Full definition →		19.18	19.39	23.98	26.48
EV/FCF Full definition →		19.39	19.57	24.25	26.69
Quick Ratio Full definition →		3.09	3.14	3.21	3.12
Current Ratio Full definition →		3.79	3.79	3.90	3.91
Net Debt/EBITDA Full definition →		(20.46)	(15.74)	(19.01)	(10.39)
Debt/Assets Full definition →		0.00%	0.00%	0.00%	0.00%
Debt/Equity Full definition →		0.00	0.00	0.00	0.00
Asset Turnover Full definition →		1.01	1.06	1.08	1.12
Operating CF/Net income Full definition →		3.80	2.22	1.86	1.00
Capex/Depreciation Full definition →		(1.36)	(0.34)	(1.40)	(0.37)
Research and Development Expense of Revenue Full definition →		17.12%	12.82%	16.79%	11.46%
Selling, General and Administrative Expense of Revenue Full definition →		28.09%	28.54%	26.22%	22.86%
Intangible Assets out of Total Assets Full definition →		0.02	0.02	0.02	0.01
Share Based Compensation of Revenue Full definition →		5.06%	4.69%	4.78%	4.57%
Graham Net Nets Full definition →		0.11	0.10	0.09	0.08
Graham Number Full definition →		11.73	13.21	14.25	17.07
Earnings Yield Full definition →		1.94%	2.04%	1.67%	1.91%
Free Cash Flow Yield Full definition →		4.46%	4.46%	3.69%	3.38%
Revenue per Share Full definition →		2.72	2.80	3.14	3.66
Operating CF per Share Full definition →		0.73	0.66	0.61	0.61
Capex per Share Full definition →		(0.01)	0.00	(0.01)	0.00
Free Cash Flow per Share Full definition →		0.72	0.65	0.60	0.61
Cash per Share Full definition →		5.58	6.12	6.78	7.27
Shareholders Equity per Share Full definition →		7.65	7.92	8.43	9.08
Interest Debt per Share Full definition →		0.00	0.00	0.00	0.00
Book value per Share Full definition →		7.65	7.92	8.43	9.08
Free Cash Flow Full definition →		53.26	50.04	46.53	47.37
Working Capital Full definition →		387.99	437.56	497.39	558.24
Capital Expenditures Full definition →		(0.63)	(0.16)	(0.66)	(0.18)
Net Current Asset Value Full definition →		331.15	374.58	426.67	477.05
EV/EBIT Full definition →		34.27	34.50	44.24	40.36
Capex to Sales Full definition →		0.00	0.00	0.00	0.00
Price to Operating Income Full definition →		39.64	39.52	49.49	44.72
Other line items
Average Receivables Full definition →		28.66	31.64	27.70	41.26
Average Payables Full definition →		2.03	13.19	10.68	5.13
Average Inventory Full definition →		40.63	47.61	59.56	74.71
Average Assets Full definition →		672.09	712.30	778.63	847.79
Average Common Equity Full definition →		503.02	531.59	574.58	622.79

Show all line items

Columns are period end dates · fundamentals updated 2 Nov 2026

Stockrow Weekly